Skip to main content
. 2021 Jun 28;13(13):3223. doi: 10.3390/cancers13133223

Table 1.

Molecular features of TCGA THCA according to FAL1 expression status.

Molecular Feature FAL1 p Value
Low Expression
n = 124 (%)
High Expression
n = 124 (%)
mRNA cluster number
1 12 (9.8) 59 (48.8) <0.0001
2 13 (10.7) 22 (18.2)
3 32 (26.2) 5 (4.1)
4 39 (32.0) 8 (6.6)
5 26 (21.3) 27 (22.3)
miRNA cluster number
1 2 (1.6) 2 (1.6) <0.0001
2 48 (39.0) 19 (15.4)
3 26 (21.1) 7 (5.7)
4 16 (13.0) 58 (47.2)
5 16 (13.0) 19 (15.4)
6 15 (12.2) 18 (14.6)
RAS mutation
Absent 122 (98.4) 89 (72.4) <0.0001
Present 2 (1.6) 34 (27.6)
BRAF mutation
Absent 31 (25.0) 97 (78.9) <0.0001
Present 93 (75.0) 26 (21.1)
TERT promoter mutation
Absent 88 (87.1) 81 (89.0) 0.688
Present 13 (12.9) 10 (11.0)
RAS/RAF score −0.67 ± 0.49 0.21 ± 0.67 <0.0001 *
ERK score 11.37 ± 16.27 2.14 ± 20.26 0.001 *
Differentiation score −0.49 ± 0.99 0.54 ± 1.08 <0.0001 *
Akt pT308 −0.02 ± 0.64 0.06 ± 0.47 0.275 *
Akt pS473 −0.02 ± 0.47 0.09 ± 0.34 0.047 *

TCGA, The Cancer Genome Atlas; THCA, thyroid carcinoma.  p values calculated by Student’s t test; * p values calculated by chi-square test or linear-by-linear association.